Trademarkia Logo

Canada

C$
NANTKWEST
REGISTERED

on 16 Nov 2020

Last Applicant/ Owned by

ImmunityBio, Inc.

3530 John Hopkins CourtSan Diego, California 92121

US

Serial Number

1829624 filed on 27th Mar 2017

Registration Number

TMA1087709 registered on 16th Nov 2020

Registration expiry Date

16th Nov 2030

Correspondent Address

PIASETZKI NENNIGER KVAS LLP

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

NANTKWEST

Trademark usage description

cells and cell-derived preparations, namely, human-derived lymphocytes, natural killer cells and natural killer cell-derived preparations, for scienti Read More

Classification Information


Class [001]
Cells and cell-derived preparations, namely, human-derived lymphocytes, natural killer cells and natural killer cell-derived preparations, for scientific, laboratory, medical, clinical laboratory and therapeutic research in the fields of the treatment of cancer, systemic and organ specific viral, fungal and parasitic infections, and autoimmune, transplant rejection and rare genetic defect related inflammatory diseases and for antibody and biologic product testing and assessment in the fields of the aforesaid.


Classification kind code

11

Class [005]
Cell-derived preparations, namely, human-derived lymphocytes and natural killer cell-derived preparations for clinical laboratory, medicinal, and therapeutic purposes in the fields of the treatment of cancer, systemic and organ specific viral, fungal and parasitic infections, and autoimmune, transplant rejection and rare genetic defect related inflammatory diseases and for antibody and biologic product testing and assessment in the fields of the aforesaid.


Classification kind code

11

Class [042]
Research in the fields of cancer and infectious and inflammatory diseases; product development in the fields of science, medicine, pharmaceuticals, and therapeutics; research in the field of development of new products for others.


Classification kind code

11

Class [044]
Providing information about the clinical laboratory, pharmacological, medicinal, and therapeutic properties of cells and cell-derived preparations, namely, human-derived lymphocytes and natural killer cell-derived preparations in the fields of the treatment of cancer, systemic and organ specific viral, fungal and parasitic infections, and autoimmune, transplant rejection and rare genetic defect related inflammatory diseases and for antibody and biologic product testing and assessment in the fields of the aforesaid.


Classification kind code

11

Mark Details


Serial Number

1829624

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 67
on 11th Sept 2019
Agent Name Changed
Submitted for opposition 12
on 9th Apr 2019
Extension of Time
Submitted for opposition 87
on 3rd Apr 2019
Rep for Service Changed
Submitted for opposition 48
on 3rd Apr 2019
Agent Changed
Submitted for opposition 15
on 3rd Oct 2018
Correspondence Created
Submitted for opposition 22
on 13th Feb 2018
Search Recorded
Submitted for opposition 20
on 13th Feb 2018
Examiner's First Report
Submitted for opposition 31
on 3rd Apr 2017
Formalized
Submitted for opposition 1
on 28th Mar 2017
Created
Submitted for opposition 30
on 27th Mar 2017
Filed